227 related articles for article (PubMed ID: 18311747)
1. Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy.
Tanaka S; Arii S; Yasen M; Mogushi K; Su NT; Zhao C; Imoto I; Eishi Y; Inazawa J; Miki Y; Tanaka H
Br J Surg; 2008 May; 95(5):611-9. PubMed ID: 18311747
[TBL] [Abstract][Full Text] [Related]
2. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
[TBL] [Abstract][Full Text] [Related]
3. Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue.
Yasen M; Mizushima H; Mogushi K; Obulhasim G; Miyaguchi K; Inoue K; Nakahara I; Ohta T; Aihara A; Tanaka S; Arii S; Tanaka H
Cancer Sci; 2009 Mar; 100(3):472-80. PubMed ID: 19134008
[TBL] [Abstract][Full Text] [Related]
4. Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma.
Eguchi S; Kanematsu T; Arii S; Omata M; Kudo M; Sakamoto M; Takayasu K; Makuuchi M; Matsuyama Y; Monden M;
Br J Surg; 2011 Apr; 98(4):552-7. PubMed ID: 21267990
[TBL] [Abstract][Full Text] [Related]
5. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.
Chun JM; Kwon HJ; Sohn J; Kim SG; Park JY; Bae HI; Yun YK; Hwang YJ
J Surg Oncol; 2011 Feb; 103(2):148-51. PubMed ID: 21259248
[TBL] [Abstract][Full Text] [Related]
7. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
9. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection.
Zhou H; Huang H; Shi J; Zhao Y; Dong Q; Jia H; Liu Y; Ye Q; Sun H; Zhu X; Fu L; Guo K; Gao D; Sun J; Yan Z; Ren N; Tang Z; Qin L
Gut; 2010 Dec; 59(12):1699-708. PubMed ID: 20940284
[TBL] [Abstract][Full Text] [Related]
11. [Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].
Gugenheim J; Baldini E; Casaccia M; Ouzan D; Saint-Paul MC; Mouiel J
Gastroenterol Clin Biol; 1997; 21(8-9):590-5. PubMed ID: 9587497
[TBL] [Abstract][Full Text] [Related]
12. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome.
Wang K; Liu J; Yan ZL; Li J; Shi LH; Cong WM; Xia Y; Zou QF; Xi T; Shen F; Wang HY; Wu MC
Hepatology; 2010 Jul; 52(1):164-73. PubMed ID: 20578260
[TBL] [Abstract][Full Text] [Related]
14. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
Tanaka S; Mogushi K; Yasen M; Noguchi N; Kudo A; Kurokawa T; Nakamura N; Inazawa J; Tanaka H; Arii S
J Am Coll Surg; 2009 Mar; 208(3):368-74. PubMed ID: 19317998
[TBL] [Abstract][Full Text] [Related]
15. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
[TBL] [Abstract][Full Text] [Related]
16. Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
Takada Y; Otsuka M; Todoroki T; Fukao K
Hepatogastroenterology; 2003; 50(54):1991-5. PubMed ID: 14696450
[TBL] [Abstract][Full Text] [Related]
17. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
Bhaijee F; Locketz ML; Krige JE
S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
[TBL] [Abstract][Full Text] [Related]
18. Predictive markers for postsurgical recurrence of hepatocellular carcinoma.
Gao ZH
J Surg Oncol; 2005 Dec; 92(4):274-5. PubMed ID: 16299794
[No Abstract] [Full Text] [Related]
19. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
Jeng KS; Sheen IS; Tsai YC
Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
[TBL] [Abstract][Full Text] [Related]
20. Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma.
An HJ; Jang JW; Bae SH; Choi JY; Cho SH; Yoon SK; Han JY; Lee KH; Kim DG; Jung ES
J Gastroenterol Hepatol; 2010 Dec; 25(12):1876-82. PubMed ID: 21092000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
